Literature DB >> 27650269

Rates and risk factors of hypertension in adolescents and adults with sickle cell anaemia in Tanzania: 10 years' experience.

Abel Makubi1,2,3, Bruno P Mmbando2,4, Enrico M Novelli5, Johnson Lwakatare3,6, Deogratius Soka2, Harvest Marik2, Kemi Tibarazwa3,6, Mariam Ngaeje2, Charles R Newton2, Mark T Gladwin6,7, Julie Makani1,2,8.   

Abstract

Data on the magnitude and risk factors for hypertension in sickle cell anaemia (SCA) are limited. A retrospective analysis of individuals with SCA aged ≥15 years enrolled from 2004-2014 at Muhimbili National Hospital, Tanzania was conducted to determine the prevalence, incidence and risk factors for hypertension. A total of 1013 individuals with SCA were analysed, of whom 571(56%) were females. The median age [interquartile range] was 17 [15-22] years. Four hundred and forty-one (44%) of the patients had relative hypertension [systolic blood pressure (SBP) 120-139 mmHg or diastolic blood pressure (DBP) 70-89 mmHg], and 79 (8%) had hypertension (SBP ≥ 140 mmHg or DBP ≥ 90 mmHg). The incidence of hypertension was 64/1000 person years of observation and the 5-year survival rate was 0·71 [95% confidence interval (CI): 0·67-0·75]. In multivariate analysis, age>18 years, Hazard ratio (HR) 1·50 (95% CI: 1·03-2·18); pulse pressure, HR 0·64 (95% CI: 0·42 to 0·98); pulse rate, 1·02 (95% CI: 1·01-1·03); body mass index (BMI), HR 1·08 (95% CI: 1·03-1·13); blood transfusion, HR 2·50 (95% CI: 1·01-6·21) and haemoglobin, HR 1·12 (95% CI: 1·05-1·33) were independently associated with hypertension. In conclusion, despite the younger age, hypertension in this population was higher than that reported in others studies. Age, BMI, pulse pressure and haemoglobin were independently associated with hypertension in SCA.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  Tanzania; hypertension; incidence; prevalence; sickle cell

Mesh:

Year:  2016        PMID: 27650269      PMCID: PMC5612392          DOI: 10.1111/bjh.14330

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  28 in total

Review 1.  Arterial blood pressure and hyperviscosity in sickle cell disease.

Authors:  Cage S Johnson
Journal:  Hematol Oncol Clin North Am       Date:  2005-10       Impact factor: 3.722

2.  Arterial blood pressure in adults with sickle cell disease.

Authors:  C S Johnson; A J Giorgio
Journal:  Arch Intern Med       Date:  1981-06

Review 3.  The inherited diseases of hemoglobin are an emerging global health burden.

Authors:  David J Weatherall
Journal:  Blood       Date:  2010-03-16       Impact factor: 22.113

4.  Regional disparities in the incidence of elevated blood pressure among young adults: the CARDIA study.

Authors:  C I Kiefe; O D Williams; D E Bild; C E Lewis; J E Hilner; A Oberman
Journal:  Circulation       Date:  1997-08-19       Impact factor: 29.690

5.  Contemporary aetiology, clinical characteristics and prognosis of adults with heart failure observed in a tertiary hospital in Tanzania: the prospective Tanzania Heart Failure (TaHeF) study.

Authors:  Abel Makubi; Camilla Hage; Johnson Lwakatare; Peter Kisenge; Julie Makani; Lars Rydén; Lars H Lund
Journal:  Heart       Date:  2014-04-17       Impact factor: 5.994

6.  A time bomb of cardiovascular risk factors in South Africa: results from the Heart of Soweto Study "Heart Awareness Days".

Authors:  Kemi Tibazarwa; Lucas Ntyintyane; Karen Sliwa; Trevor Gerntholtz; Melinda Carrington; David Wilkinson; Simon Stewart
Journal:  Int J Cardiol       Date:  2008-01-30       Impact factor: 4.164

7.  Determinants of isolated systolic hypertension in the elderly.

Authors:  W W Nichols; F A Nicolini; C J Pepine
Journal:  J Hypertens Suppl       Date:  1992-08

8.  Hypertension in sub-Saharan Africa: cross-sectional surveys in four rural and urban communities.

Authors:  Marleen E Hendriks; Ferdinand W N M Wit; Marijke T L Roos; Lizzy M Brewster; Tanimola M Akande; Ingrid H de Beer; Sayoki G Mfinanga; Amos M Kahwa; Peter Gatongi; Gert Van Rooy; Wendy Janssens; Judith Lammers; Berber Kramer; Igna Bonfrer; Esegiel Gaeb; Jacques van der Gaag; Tobias F Rinke de Wit; Joep M A Lange; Constance Schultsz
Journal:  PLoS One       Date:  2012-03-12       Impact factor: 3.240

9.  Male gender, increased blood viscosity, body mass index and triglyceride levels are independently associated with systemic relative hypertension in sickle cell anemia.

Authors:  Yann Lamarre; Marie-Laure Lalanne-Mistrih; Marc Romana; Nathalie Lemonne; Daniele Mougenel; Xavier Waltz; Benoît Tressières; Maryse Etienne-Julan; Vanessa Tarer; Marie-Dominique Hardy-Dessources; Philippe Connes
Journal:  PLoS One       Date:  2013-06-13       Impact factor: 3.240

10.  Comparison of patients from Nigeria and the USA highlights modifiable risk factors for sickle cell anemia complications.

Authors:  Titilola S Akingbola; Bamidele O Tayo; Babatunde Salako; Jennifer E Layden; Lewis L Hsu; Richard S Cooper; Victor R Gordeuk; Santosh L Saraf
Journal:  Hemoglobin       Date:  2014-06-18       Impact factor: 0.849

View more
  3 in total

1.  Clinical characteristics and risk factors of relative systemic hypertension and hypertension among sickle cell patients in Cameroon.

Authors:  Arthemon Nguweneza; Valentina Josiane Ngo Bitoungui; Khuthala Mnika; Gaston Mazandu; Victoria Nembaware; Andre P Kengne; Ambroise Wonkam
Journal:  Front Med (Lausanne)       Date:  2022-07-19

2.  A ten year review of the sickle cell program in Muhimbili National Hospital, Tanzania.

Authors:  Lucio Luzzatto; Bruno P Mmbando; Julie Makani; Furahini Tluway; Abel Makubi; Deogratius Soka; Siana Nkya; Raphael Sangeda; Josephine Mgaya; Stella Rwezaula; Fenella J Kirkham; Christina Kindole; Elisha Osati; Elineema Meda; Robert W Snow; Charles R Newton; David Roberts; Muhsin Aboud; Swee Lay Thein; Sharon E Cox
Journal:  BMC Hematol       Date:  2018-11-14

3.  Impact of relative systemic hypertension on the heart in sickle cell anaemia.

Authors:  Opeyemi O Oni; Adewole A Adebiyi; Akinyemi Aje; Titilola S Akingbola
Journal:  Indian Heart J       Date:  2020-05-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.